Search Keyword:


Search option:


IID50045
UniprotP47811
ProteinMitogen-activated protein kinase 14
GeneMapk14
OrganismMus musculus
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
360
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 1-360 Hetero dimer : Q15750
 Evidence X-RAY 5o90 A Reference
       Region 5o90 A 1-4 disorder
       Region 5o90 A 5-172 order
       Region 5o90 A 173-181 disorder
       Region 5o90 A 182-250 order
       Region 5o90 A 251-260 disorder
       Region 5o90 A 261-353 order
       Region 5o90 A 354-360 disorder
Seq 1-360 Hetero dimer :
 Evidence X-RAY 3p4k A Reference
       Region 3p4k A 1-3 disorder
       Region 3p4k A 4-171 order
       Region 3p4k A 172-183 disorder
       Region 3p4k A 184-353 order
       Region 3p4k A 354-360 disorder
Seq 1-360 Hetero dimer : Q9Y6W6
 Evidence X-RAY 3tg1 A Reference
       Region 3tg1 A 1-4 disorder
       Region 3tg1 A 5-169 order
       Region 3tg1 A 170-183 disorder
       Region 3tg1 A 184-352 order
       Region 3tg1 A 353-360 disorder
Seq 1-360 Hetero dimer : IID00240Complex
 Evidence X-RAY 1lew A Reference
       Region 1lew A 1-4 disorder
       Region 1lew A 5-173 order
       Region 1lew A 174-182 disorder
       Region 1lew A 183-354 order
       Region 1lew A 355-360 disorder
Seq 1-360 Monomer :
 Evidence X-RAY 5lar A Reference
       Region 5lar A 1-3 disorder
       Region 5lar A 4-353 order
       Region 5lar A 354-360 disorder
 Evidence X-RAY 1ywr A Reference
       Region 1ywr A 1-4 disorder
       Region 1ywr A 5-116 order
       Region 1ywr A 117-117 disorder
       Region 1ywr A 118-173 order
       Region 1ywr A 174-182 disorder
       Region 1ywr A 183-352 order
       Region 1ywr A 353-360 disorder
 Evidence X-RAY 1yw2 A Reference
       Region 1yw2 A 1-3 disorder
       Region 1yw2 A 4-170 order
       Region 1yw2 A 171-171 disorder
       Region 1yw2 A 172-174 order
       Region 1yw2 A 175-182 disorder
       Region 1yw2 A 183-353 order
       Region 1yw2 A 354-360 disorder
 Evidence X-RAY 5uoj A Reference
       Region 5uoj A 1-4 disorder
       Region 5uoj A 5-172 order
       Region 5uoj A 173-178 disorder
       Region 5uoj A 179-353 order
       Region 5uoj A 354-360 disorder
 Evidence X-RAY 3py3 A The activation loop is described to be disordered. Reference
       Region 3py3 A 1-354 order
       Region 3py3 A 355-360 disorder
 Evidence X-RAY 2puu A Reference
       Region 2puu A 5-30 order
       Region 2puu A 31-36 disorder
       Region 2puu A 37-170 order
       Region 2puu A 171-182 disorder
       Region 2puu A 183-352 order
 Evidence X-RAY 3p7c A Reference
       Region 3p7c A 2-4 disorder
       Region 3p7c A 5-32 order
       Region 3p7c A 33-35 disorder
       Region 3p7c A 36-170 order
       Region 3p7c A 171-183 disorder
       Region 3p7c A 184-352 order
       Region 3p7c A 353-360 disorder
 Evidence X-RAY 3p7b A Reference
       Region 3p7b A 2-4 disorder
       Region 3p7b A 5-32 order
       Region 3p7b A 33-35 disorder
       Region 3p7b A 36-170 order
       Region 3p7b A 171-183 disorder
       Region 3p7b A 184-352 order
       Region 3p7b A 353-360 disorder
 Evidence X-RAY 3p7a A Reference
       Region 3p7a A 2-4 disorder
       Region 3p7a A 5-32 order
       Region 3p7a A 33-35 disorder
       Region 3p7a A 36-170 order
       Region 3p7a A 171-183 disorder
       Region 3p7a A 184-352 order
       Region 3p7a A 353-360 disorder
 Evidence X-RAY 3p79 A Reference
       Region 3p79 A 2-4 disorder
       Region 3p79 A 5-32 order
       Region 3p79 A 33-35 disorder
       Region 3p79 A 36-170 order
       Region 3p79 A 171-183 disorder
       Region 3p79 A 184-352 order
       Region 3p79 A 353-360 disorder
 Evidence X-RAY 3p78 A Reference
       Region 3p78 A 2-4 disorder
       Region 3p78 A 5-32 order
       Region 3p78 A 33-35 disorder
       Region 3p78 A 36-170 order
       Region 3p78 A 171-183 disorder
       Region 3p78 A 184-352 order
       Region 3p78 A 353-360 disorder
 Evidence X-RAY 3p5k A Reference
       Region 3p5k A 2-4 disorder
       Region 3p5k A 5-32 order
       Region 3p5k A 33-35 disorder
       Region 3p5k A 36-170 order
       Region 3p5k A 171-183 disorder
       Region 3p5k A 184-352 order
       Region 3p5k A 353-360 disorder
 Evidence X-RAY 2gtn A Reference
       Region 2gtn A 5-172 order
       Region 2gtn A 173-183 disorder
       Region 2gtn A 184-352 order
 Evidence X-RAY 2gtm A Reference
       Region 2gtm A 5-118 order
       Region 2gtm A 119-121 disorder
       Region 2gtm A 122-177 order
       Region 2gtm A 178-181 disorder
       Region 2gtm A 182-352 order
 Evidence X-RAY 2ghm A Reference
       Region 2ghm A 5-119 order
       Region 2ghm A 120-120 disorder
       Region 2ghm A 121-171 order
       Region 2ghm A 172-182 disorder
       Region 2ghm A 183-352 order
 Evidence X-RAY 2ghl A Reference
       Region 2ghl A 5-117 order
       Region 2ghl A 118-121 disorder
       Region 2ghl A 122-173 order
       Region 2ghl A 174-183 disorder
       Region 2ghl A 184-352 order
 Evidence X-RAY 2ewa A Reference
       Region 2ewa A 1-4 disorder
       Region 2ewa A 5-116 order
       Region 2ewa A 117-121 disorder
       Region 2ewa A 122-170 order
       Region 2ewa A 171-184 disorder
       Region 2ewa A 185-196 order
       Region 2ewa A 197-197 disorder
       Region 2ewa A 198-354 order
       Region 2ewa A 355-360 disorder
Seq 1-360 Hetero dimer : Q15750
 Evidence X-RAY 4ka3 A Reference
       Region 4ka3 A 1-3 disorder
       Region 4ka3 A 4-172 order
       Region 4ka3 A 173-183 disorder
       Region 4ka3 A 184-354 order
       Region 4ka3 A 355-360 disorder
Seq 1-360 Hetero dimer : IID50233Complex
 Evidence X-RAY 4loq D Several regions including the DFG motif is described to be disordered. Reference
       Region 4loq D 1-3 disorder
       Region 4loq D 4-354 order
       Region 4loq D 355-360 disorder
 Evidence X-RAY 4loq C Several regions including the DFG motif is described to be disordered. Reference
       Region 4loq C 1-3 disorder
       Region 4loq C 4-245 order
       Region 4loq C 246-258 disorder
       Region 4loq C 259-353 order
       Region 4loq C 354-360 disorder
 Evidence X-RAY 4loq B Several regions including the DFG motif is described to be disordered. Reference
       Region 4loq B 1-2 disorder
       Region 4loq B 3-353 order
       Region 4loq B 354-360 disorder
 Evidence X-RAY 4loq A Several regions including the DFG motif is described to be disordered. Reference
       Region 4loq A 1-2 disorder
       Region 4loq A 3-354 order
       Region 4loq A 355-360 disorder
 Evidence X-RAY 4lop D Several regions including the DFG motif is described to be disordered. Reference
       Region 4lop D 1-2 disorder
       Region 4lop D 3-353 order
       Region 4lop D 354-360 disorder
 Evidence X-RAY 4lop C Several regions including the DFG motif is described to be disordered. Reference
       Region 4lop C 1-2 disorder
       Region 4lop C 3-246 order
       Region 4lop C 247-256 disorder
       Region 4lop C 257-353 order
       Region 4lop C 354-360 disorder
 Evidence X-RAY 4lop B Several regions including the DFG motif is described to be disordered. Reference
       Region 4lop B 1-3 disorder
       Region 4lop B 4-353 order
       Region 4lop B 354-360 disorder
 Evidence X-RAY 4lop A Several regions including the DFG motif is described to be disordered. Reference
       Region 4lop A 1-2 disorder
       Region 4lop A 3-353 order
       Region 4lop A 354-360 disorder
 Evidence X-RAY 4loo A Several regions including the DFG motif is described to be disordered. Reference
       Region 4loo A 1-4 disorder
       Region 4loo A 5-353 order
       Region 4loo A 354-360 disorder
Seq 1-360 Hetero dimer : IID50191Complex
 Evidence X-RAY 1lez A Reference
       Region 1lez A 1-3 disorder
       Region 1lez A 4-174 order
       Region 1lez A 175-181 disorder
       Region 1lez A 182-353 order
       Region 1lez A 354-360 disorder
Seq 2-360 Hetero dimer : IID00271Complex
 Evidence X-RAY 4tyh B Reference
       Region 4tyh B 6-172 order
       Region 4tyh B 173-180 disorder
       Region 4tyh B 181-194 order
       Region 4tyh B 195-199 disorder
       Region 4tyh B 200-353 order
 Evidence X-RAY 2oza B Reference
       Region 2oza B 2-5 disorder
       Region 2oza B 6-172 order
       Region 2oza B 173-180 disorder
       Region 2oza B 181-353 order
       Region 2oza B 354-360 disorder
Seqphosphorylation
    180-180 Phosphothreonine; by MAP2K3
    2-2 Phosphoserine
    16-16 Phosphothreonine
    180-180 Phosphothreonine
    182-182 Phosphotyrosine
    182-182 Phosphotyrosine; by MAP2K3
    323-323 Phosphotyrosine; by ZAP70
Seqacetylation
    2-2 N-acetylserine
    53-53 N6-acetyllysine
    152-152 N6-acetyllysine
 
Prediction
NeProc
Disorder 1-5,354-360
Order 6-353
AlphaFold
Disorder 1-3,172-184,198-198,354-360
Order 4-171,185-197,199-353
Pfam Hmmer
PF00069 24-308 7e-87
SEG 299-312
Function
Function in SwissProt
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1. RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2. MAPK14 interacts also with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53. In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3. MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9. Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14-mediated phosphorylation of EGFR itself as well as of RAB5A effectors. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A. The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation. Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation. The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression. Phosphorylates S100A9 at 'Thr-113' (By similarity).